ARTICLE | Clinical News
Stacatto alprazolam: Preliminary Phase IIa data
June 16, 2008 7:00 AM UTC
Preliminary data from a double-blind, U.S. Phase IIa trial in 40 patients showed that AZ-002 missed its 2 primary endpoints of significantly reducing the incidence and duration of a doxapram-induced p...